Here are the 10-K annual reports from Syra Health Corp A (SYRA) in our archive since June 2025, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A 10-K covers the audited annual report, with the full financial statements, so if you follow SYRA and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full SYRA filings page.
Syra Health Corp. filed Amendment No. 1 to its annual report to add detailed Part III information on directors, executive compensation, ownership and auditor fees, without changing previously issued financial statements. The filing confirms Gregory R. Alexander as Chief Executive Officer effective January 5, 2026 with a base salary of $251,000, equity awards and change‑of‑control protections. It outlines compensation for former leaders, including the prior CEO and president, and notes no bonuses were paid for 2025. The amendment describes board and committee cash retainers, substantial option grants to non‑employee directors, and the 2022 Omnibus Equity Incentive Plan with 1,041,667 shares reserved. It also discloses related‑party service and lease arrangements, major shareholders’ voting power, and audit and audit‑related fees paid to M&K for 2025 and 2024.
Syra Health Corp. filed its annual report describing a small but loss-making healthcare solutions business focused on mental health, population health, digital health, education, and staffing. The company generated approximately $7.2 million of revenue in 2025, down from $8.0 million in 2024, and reported net losses of $896,333 and $3,759,238 for those years. Cash was $1,614,733 as of December 31, 2025, and its auditors expressed substantial doubt about its ability to continue as a going concern, highlighting the need for substantial additional funding. Syra operates in heavily regulated healthcare and government-contract markets and outlines numerous operational, regulatory, technology, data security, concentration, and staffing risks that could materially affect its business. Non-affiliate equity market value was about $979,537 as of June 30, 2025, with 11,339,169 Class A shares outstanding as of March 12, 2026.